Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 93 | 2023 | 4823 | 9.230 |
Why?
|
Pathology | 31 | 2018 | 272 | 8.720 |
Why?
|
Granulosa Cell Tumor | 13 | 2023 | 70 | 6.840 |
Why?
|
Testicular Neoplasms | 37 | 2023 | 761 | 6.810 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 23 | 2023 | 105 | 6.510 |
Why?
|
Gynecology | 24 | 2018 | 509 | 6.440 |
Why?
|
Endodermal Sinus Tumor | 10 | 2022 | 47 | 3.740 |
Why?
|
Thecoma | 6 | 2023 | 11 | 3.270 |
Why?
|
Uterine Neoplasms | 26 | 2024 | 1513 | 2.760 |
Why?
|
Sertoli Cell Tumor | 7 | 2023 | 40 | 2.710 |
Why?
|
Carcinoma, Endometrioid | 11 | 2021 | 271 | 2.530 |
Why?
|
History, 20th Century | 39 | 2022 | 2739 | 2.440 |
Why?
|
Ovarian Cysts | 6 | 2021 | 115 | 2.400 |
Why?
|
Endometrial Neoplasms | 15 | 2023 | 1351 | 2.280 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 10 | 2022 | 484 | 2.270 |
Why?
|
Sertoli-Leydig Cell Tumor | 6 | 2021 | 15 | 2.050 |
Why?
|
Pathology, Clinical | 6 | 2019 | 368 | 1.910 |
Why?
|
Diagnosis, Differential | 82 | 2022 | 12958 | 1.890 |
Why?
|
Endometrial Stromal Tumors | 7 | 2023 | 44 | 1.840 |
Why?
|
Adenocarcinoma, Mucinous | 11 | 2020 | 505 | 1.830 |
Why?
|
Pathology, Surgical | 5 | 2021 | 155 | 1.740 |
Why?
|
Sarcoma, Endometrial Stromal | 8 | 2023 | 91 | 1.730 |
Why?
|
Krukenberg Tumor | 7 | 2018 | 16 | 1.730 |
Why?
|
Immunohistochemistry | 58 | 2023 | 11363 | 1.650 |
Why?
|
Cystadenoma, Mucinous | 4 | 2022 | 59 | 1.600 |
Why?
|
Adenocarcinoma, Clear Cell | 7 | 2016 | 221 | 1.600 |
Why?
|
Endometriosis | 6 | 2022 | 834 | 1.580 |
Why?
|
Appendiceal Neoplasms | 9 | 2014 | 145 | 1.400 |
Why?
|
Seminoma | 8 | 2019 | 136 | 1.400 |
Why?
|
Ovarian Diseases | 3 | 2021 | 139 | 1.370 |
Why?
|
History, 21st Century | 16 | 2021 | 1533 | 1.330 |
Why?
|
Ovarian Follicle | 4 | 2021 | 247 | 1.320 |
Why?
|
History, 19th Century | 17 | 2018 | 720 | 1.280 |
Why?
|
Vaginal Neoplasms | 4 | 2014 | 106 | 1.270 |
Why?
|
Peritoneum | 2 | 2022 | 226 | 1.240 |
Why?
|
Carcinoma | 11 | 2020 | 2374 | 1.210 |
Why?
|
Carcinoma, Transitional Cell | 10 | 2008 | 798 | 1.190 |
Why?
|
Gonads | 2 | 2022 | 107 | 1.120 |
Why?
|
Polyps | 3 | 2014 | 189 | 1.090 |
Why?
|
Pregnancy Complications, Neoplastic | 4 | 2020 | 253 | 1.070 |
Why?
|
Cystadenocarcinoma, Mucinous | 3 | 2014 | 49 | 1.070 |
Why?
|
Fallopian Tube Neoplasms | 4 | 2016 | 324 | 1.060 |
Why?
|
Dysgerminoma | 2 | 2021 | 52 | 1.020 |
Why?
|
Teratoma | 7 | 2022 | 387 | 1.020 |
Why?
|
Carcinoma, Small Cell | 5 | 2022 | 420 | 1.000 |
Why?
|
Luteinization | 4 | 2021 | 9 | 0.990 |
Why?
|
Ovary | 9 | 2022 | 981 | 0.990 |
Why?
|
Appendix | 4 | 2014 | 110 | 0.980 |
Why?
|
Leiomyoma | 7 | 2024 | 728 | 0.940 |
Why?
|
Adenocarcinoma | 17 | 2022 | 6347 | 0.940 |
Why?
|
Female | 176 | 2024 | 379592 | 0.930 |
Why?
|
Urinary Bladder Diseases | 3 | 2010 | 166 | 0.890 |
Why?
|
Peutz-Jeghers Syndrome | 3 | 2021 | 50 | 0.890 |
Why?
|
Humans | 244 | 2024 | 742088 | 0.860 |
Why?
|
Cysts | 4 | 2022 | 676 | 0.830 |
Why?
|
Follicular Cyst | 1 | 2021 | 2 | 0.830 |
Why?
|
Adenoma | 5 | 2019 | 2168 | 0.830 |
Why?
|
Urinary Bladder Neoplasms | 10 | 2014 | 2229 | 0.810 |
Why?
|
Mixed Tumor, Malignant | 1 | 2021 | 15 | 0.810 |
Why?
|
Adult | 122 | 2023 | 213712 | 0.780 |
Why?
|
Penile Neoplasms | 3 | 2010 | 159 | 0.760 |
Why?
|
Peritoneal Neoplasms | 7 | 2014 | 663 | 0.760 |
Why?
|
Endometrium | 4 | 2021 | 424 | 0.740 |
Why?
|
Genital Neoplasms, Female | 4 | 2022 | 516 | 0.740 |
Why?
|
Adenomatoid Tumor | 3 | 2021 | 13 | 0.730 |
Why?
|
Middle Aged | 107 | 2022 | 213127 | 0.680 |
Why?
|
Eponyms | 3 | 2015 | 15 | 0.680 |
Why?
|
Testis | 3 | 2021 | 800 | 0.670 |
Why?
|
Peritonitis | 2 | 2013 | 365 | 0.670 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2022 | 385 | 0.660 |
Why?
|
Leiomyosarcoma | 5 | 2019 | 477 | 0.660 |
Why?
|
beta Catenin | 6 | 2023 | 1058 | 0.660 |
Why?
|
Forkhead Transcription Factors | 3 | 2015 | 1613 | 0.650 |
Why?
|
Uterine Cervical Neoplasms | 6 | 2022 | 2011 | 0.640 |
Why?
|
Ribonuclease III | 6 | 2022 | 275 | 0.640 |
Why?
|
Stromal Cells | 5 | 2014 | 1353 | 0.630 |
Why?
|
Smooth Muscle Tumor | 4 | 2014 | 67 | 0.630 |
Why?
|
DEAD-box RNA Helicases | 6 | 2022 | 375 | 0.600 |
Why?
|
Cervix Uteri | 5 | 2022 | 591 | 0.600 |
Why?
|
Tumor Burden | 8 | 2021 | 1905 | 0.590 |
Why?
|
Cecal Diseases | 3 | 2009 | 51 | 0.580 |
Why?
|
Aged | 86 | 2022 | 162944 | 0.570 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2016 | 450 | 0.570 |
Why?
|
Urologic Diseases | 1 | 2019 | 244 | 0.550 |
Why?
|
Brenner Tumor | 3 | 2007 | 8 | 0.550 |
Why?
|
Young Adult | 32 | 2022 | 56350 | 0.530 |
Why?
|
Peritoneal Diseases | 2 | 2014 | 75 | 0.530 |
Why?
|
Fibroma | 3 | 2021 | 212 | 0.520 |
Why?
|
Orchiectomy | 7 | 2017 | 466 | 0.510 |
Why?
|
Neoplasm Invasiveness | 12 | 2015 | 3612 | 0.510 |
Why?
|
Reference Books, Medical | 2 | 2005 | 22 | 0.510 |
Why?
|
Periodicals as Topic | 4 | 2019 | 1431 | 0.500 |
Why?
|
Mesothelioma, Cystic | 1 | 2014 | 4 | 0.500 |
Why?
|
WT1 Proteins | 1 | 2015 | 178 | 0.500 |
Why?
|
Urachus | 1 | 2014 | 18 | 0.500 |
Why?
|
Carcinoma, Signet Ring Cell | 3 | 2018 | 83 | 0.500 |
Why?
|
Luteoma | 1 | 2014 | 3 | 0.490 |
Why?
|
Gallbladder Neoplasms | 2 | 2008 | 183 | 0.480 |
Why?
|
Aged, 80 and over | 41 | 2022 | 57683 | 0.480 |
Why?
|
Rhabdomyosarcoma, Embryonal | 3 | 2022 | 102 | 0.480 |
Why?
|
Progestins | 1 | 2016 | 303 | 0.470 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1585 | 0.470 |
Why?
|
Urology | 1 | 2019 | 397 | 0.470 |
Why?
|
Adenosarcoma | 5 | 2022 | 34 | 0.470 |
Why?
|
Steroidogenic Factor 1 | 1 | 2013 | 46 | 0.470 |
Why?
|
Placenta | 2 | 2020 | 1694 | 0.470 |
Why?
|
Cyclin D1 | 1 | 2015 | 462 | 0.460 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2015 | 199 | 0.440 |
Why?
|
Adolescent | 39 | 2022 | 85649 | 0.430 |
Why?
|
Bile Duct Neoplasms | 2 | 2008 | 567 | 0.430 |
Why?
|
Terminology as Topic | 5 | 2019 | 1548 | 0.430 |
Why?
|
Biopsy | 14 | 2022 | 6756 | 0.430 |
Why?
|
Histocytological Preparation Techniques | 2 | 2011 | 30 | 0.430 |
Why?
|
Neoplasm Staging | 18 | 2021 | 11001 | 0.420 |
Why?
|
Endometrial Hyperplasia | 1 | 2013 | 96 | 0.420 |
Why?
|
Pathology Department, Hospital | 1 | 2011 | 10 | 0.410 |
Why?
|
Hypercalcemia | 2 | 2016 | 405 | 0.410 |
Why?
|
Vulvar Diseases | 2 | 2011 | 61 | 0.410 |
Why?
|
Edema | 2 | 2008 | 790 | 0.410 |
Why?
|
Sclerosis | 3 | 2023 | 210 | 0.410 |
Why?
|
Leuprolide | 2 | 2004 | 303 | 0.410 |
Why?
|
Carcinoma, Embryonal | 3 | 2021 | 38 | 0.400 |
Why?
|
Neprilysin | 5 | 2010 | 439 | 0.400 |
Why?
|
Obstetrics | 1 | 2018 | 657 | 0.400 |
Why?
|
Prostatic Neoplasms | 13 | 2013 | 11039 | 0.390 |
Why?
|
Granulosa Cells | 2 | 2021 | 120 | 0.390 |
Why?
|
Solitary Fibrous Tumors | 2 | 2022 | 72 | 0.380 |
Why?
|
Schools, Medical | 2 | 2016 | 878 | 0.380 |
Why?
|
Pituitary Neoplasms | 1 | 2019 | 1340 | 0.380 |
Why?
|
Necrosis | 6 | 2022 | 1643 | 0.380 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2010 | 84 | 0.370 |
Why?
|
Gonadoblastoma | 2 | 2022 | 14 | 0.360 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2015 | 600 | 0.360 |
Why?
|
Struma Ovarii | 1 | 2009 | 10 | 0.360 |
Why?
|
Predictive Value of Tests | 15 | 2022 | 15056 | 0.360 |
Why?
|
Pregnancy Complications | 2 | 2021 | 2861 | 0.350 |
Why?
|
Carcinoid Tumor | 3 | 2007 | 235 | 0.350 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2022 | 325 | 0.340 |
Why?
|
Intestinal Diseases | 1 | 2014 | 531 | 0.340 |
Why?
|
Germinoma | 2 | 2022 | 133 | 0.330 |
Why?
|
Mitotic Index | 5 | 2020 | 172 | 0.330 |
Why?
|
Education, Medical | 2 | 2021 | 1717 | 0.330 |
Why?
|
Male | 71 | 2023 | 349538 | 0.330 |
Why?
|
Uterine Cervical Diseases | 2 | 2010 | 77 | 0.320 |
Why?
|
Cystadenoma, Serous | 2 | 2006 | 102 | 0.320 |
Why?
|
Inhibins | 4 | 2011 | 211 | 0.310 |
Why?
|
Granuloma, Plasma Cell | 2 | 2010 | 83 | 0.310 |
Why?
|
Faculty, Medical | 1 | 2016 | 1182 | 0.310 |
Why?
|
Trophoblastic Tumor, Placental Site | 2 | 2005 | 14 | 0.300 |
Why?
|
Child, Preschool | 13 | 2022 | 40955 | 0.300 |
Why?
|
Kidney Neoplasms | 7 | 2015 | 4229 | 0.300 |
Why?
|
Broad Ligament | 1 | 2007 | 5 | 0.300 |
Why?
|
Glomerulonephritis | 1 | 2009 | 372 | 0.300 |
Why?
|
Immobilization | 1 | 2008 | 236 | 0.300 |
Why?
|
Hospitals, General | 1 | 2011 | 749 | 0.300 |
Why?
|
Prostate-Specific Antigen | 8 | 2012 | 2458 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2014 | 9185 | 0.290 |
Why?
|
Child | 21 | 2022 | 77478 | 0.280 |
Why?
|
Ovariectomy | 5 | 2022 | 660 | 0.280 |
Why?
|
Hematuria | 2 | 2004 | 235 | 0.280 |
Why?
|
Prostatectomy | 5 | 2012 | 1871 | 0.280 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2006 | 46 | 0.280 |
Why?
|
Prognosis | 25 | 2022 | 29010 | 0.280 |
Why?
|
Biomedical Research | 1 | 2021 | 3306 | 0.270 |
Why?
|
Lichen Sclerosus et Atrophicus | 2 | 2011 | 28 | 0.270 |
Why?
|
Nephrology | 1 | 2009 | 260 | 0.270 |
Why?
|
Metaplasia | 3 | 2014 | 313 | 0.270 |
Why?
|
Cholangiocarcinoma | 2 | 2008 | 516 | 0.270 |
Why?
|
Pregnancy | 12 | 2021 | 29087 | 0.260 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2004 | 1509 | 0.260 |
Why?
|
Incidental Findings | 3 | 2021 | 688 | 0.260 |
Why?
|
Urologic Neoplasms | 2 | 2006 | 316 | 0.250 |
Why?
|
Pseudomyxoma Peritonei | 1 | 2004 | 20 | 0.250 |
Why?
|
Books | 1 | 2004 | 23 | 0.240 |
Why?
|
Carcinoma, Papillary | 2 | 2015 | 781 | 0.240 |
Why?
|
DNA-Binding Proteins | 4 | 2023 | 9639 | 0.240 |
Why?
|
Desmin | 5 | 2010 | 130 | 0.230 |
Why?
|
Kidney Pelvis | 1 | 2004 | 188 | 0.230 |
Why?
|
Genital Neoplasms, Male | 1 | 2004 | 74 | 0.230 |
Why?
|
Transcription Factors | 4 | 2020 | 12164 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2019 | 602 | 0.230 |
Why?
|
Prostate | 3 | 2011 | 1764 | 0.230 |
Why?
|
England | 3 | 2012 | 523 | 0.230 |
Why?
|
Diagnostic Errors | 4 | 2019 | 1255 | 0.220 |
Why?
|
Leydig Cell Tumor | 1 | 2002 | 25 | 0.220 |
Why?
|
Artifacts | 1 | 2011 | 1903 | 0.220 |
Why?
|
Boston | 6 | 2017 | 9305 | 0.220 |
Why?
|
Cystadenoma | 1 | 2003 | 84 | 0.220 |
Why?
|
Pancreatic Neoplasms | 4 | 2010 | 5249 | 0.220 |
Why?
|
Papilloma | 1 | 2003 | 148 | 0.210 |
Why?
|
Education, Medical, Continuing | 1 | 2008 | 839 | 0.210 |
Why?
|
Infarction | 1 | 2004 | 243 | 0.210 |
Why?
|
Hospitals | 1 | 2016 | 3937 | 0.210 |
Why?
|
Cell Nucleus Shape | 2 | 2014 | 16 | 0.210 |
Why?
|
Paraganglioma | 1 | 2004 | 143 | 0.210 |
Why?
|
Fumarate Hydratase | 2 | 2024 | 47 | 0.210 |
Why?
|
Repressor Proteins | 4 | 2023 | 3020 | 0.210 |
Why?
|
Trophoblasts | 1 | 2003 | 215 | 0.210 |
Why?
|
Antigens, CD34 | 5 | 2010 | 657 | 0.210 |
Why?
|
Medical Oncology | 3 | 2012 | 2235 | 0.210 |
Why?
|
Keratins | 6 | 2007 | 515 | 0.210 |
Why?
|
Genital Diseases, Female | 2 | 2013 | 197 | 0.200 |
Why?
|
Abdominal Pain | 2 | 2010 | 1059 | 0.200 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2022 | 241 | 0.200 |
Why?
|
Disease-Free Survival | 10 | 2015 | 6891 | 0.200 |
Why?
|
Mesothelioma | 2 | 2005 | 818 | 0.200 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2011 | 4029 | 0.190 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2020 | 37 | 0.190 |
Why?
|
S100 Proteins | 3 | 2006 | 259 | 0.190 |
Why?
|
Choriocarcinoma | 1 | 2021 | 123 | 0.190 |
Why?
|
Diaphragm | 1 | 2022 | 347 | 0.190 |
Why?
|
Precancerous Conditions | 2 | 2004 | 971 | 0.190 |
Why?
|
Urinary Bladder | 2 | 2004 | 1171 | 0.190 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2023 | 2638 | 0.190 |
Why?
|
Biology | 1 | 2022 | 292 | 0.180 |
Why?
|
Prostatic Hyperplasia | 1 | 2004 | 522 | 0.180 |
Why?
|
Tuberous Sclerosis | 2 | 2014 | 1029 | 0.180 |
Why?
|
Angiomyolipoma | 1 | 2002 | 186 | 0.180 |
Why?
|
Treatment Outcome | 16 | 2020 | 62966 | 0.180 |
Why?
|
Kidney Calculi | 1 | 2004 | 465 | 0.180 |
Why?
|
Vascular Neoplasms | 1 | 2002 | 175 | 0.180 |
Why?
|
Stomach Neoplasms | 2 | 2006 | 1327 | 0.180 |
Why?
|
Adnexa Uteri | 1 | 2019 | 45 | 0.180 |
Why?
|
Melanoma | 2 | 2010 | 5462 | 0.180 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2004 | 484 | 0.180 |
Why?
|
Racemases and Epimerases | 3 | 2005 | 113 | 0.180 |
Why?
|
Reticulin | 1 | 2019 | 21 | 0.170 |
Why?
|
Infant | 6 | 2022 | 35070 | 0.170 |
Why?
|
14-3-3 Proteins | 1 | 2020 | 214 | 0.170 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2005 | 642 | 0.170 |
Why?
|
Myofibroblasts | 1 | 2020 | 221 | 0.160 |
Why?
|
Hysterectomy | 5 | 2021 | 927 | 0.160 |
Why?
|
Carcinoma in Situ | 1 | 2004 | 802 | 0.160 |
Why?
|
Adnexal Diseases | 1 | 2019 | 102 | 0.160 |
Why?
|
Austria | 1 | 2018 | 201 | 0.160 |
Why?
|
Medical Illustration | 2 | 2009 | 133 | 0.160 |
Why?
|
Cell Nucleus | 3 | 2014 | 2968 | 0.160 |
Why?
|
Russia | 1 | 2018 | 409 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 4 | 2015 | 3123 | 0.150 |
Why?
|
Calmodulin-Binding Proteins | 3 | 2010 | 249 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 484 | 0.150 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2017 | 41 | 0.150 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2018 | 188 | 0.150 |
Why?
|
Hyperplasia | 2 | 2014 | 1183 | 0.140 |
Why?
|
alpha-Fetoproteins | 2 | 2015 | 222 | 0.140 |
Why?
|
Coloring Agents | 1 | 2019 | 565 | 0.140 |
Why?
|
Germany | 1 | 2018 | 860 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2022 | 594 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4553 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2940 | 0.140 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2017 | 75 | 0.140 |
Why?
|
Time Factors | 7 | 2015 | 40054 | 0.140 |
Why?
|
Neovascularization, Pathologic | 2 | 2008 | 2633 | 0.140 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2018 | 224 | 0.140 |
Why?
|
Keratin-20 | 2 | 2006 | 31 | 0.140 |
Why?
|
Vimentin | 3 | 2007 | 261 | 0.130 |
Why?
|
Keratin-7 | 2 | 2006 | 57 | 0.130 |
Why?
|
Indiana | 1 | 2015 | 92 | 0.130 |
Why?
|
Histocytochemistry | 2 | 2010 | 718 | 0.130 |
Why?
|
DNA Mutational Analysis | 4 | 2022 | 4187 | 0.130 |
Why?
|
Combined Modality Therapy | 5 | 2010 | 8621 | 0.130 |
Why?
|
Mitosis | 2 | 2023 | 1208 | 0.130 |
Why?
|
Actins | 4 | 2010 | 2120 | 0.130 |
Why?
|
Mutation | 9 | 2022 | 29717 | 0.130 |
Why?
|
United States | 11 | 2017 | 69693 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6534 | 0.130 |
Why?
|
DNA Helicases | 2 | 2020 | 861 | 0.120 |
Why?
|
Melanoma-Specific Antigens | 2 | 2006 | 80 | 0.120 |
Why?
|
Diffusion of Innovation | 1 | 2019 | 725 | 0.120 |
Why?
|
Hyalin | 1 | 2014 | 37 | 0.120 |
Why?
|
Succinate Dehydrogenase | 1 | 2015 | 146 | 0.120 |
Why?
|
Epithelial Cells | 3 | 2022 | 3678 | 0.120 |
Why?
|
Cell Proliferation | 3 | 2015 | 10472 | 0.120 |
Why?
|
Exocrine Glands | 2 | 2004 | 50 | 0.120 |
Why?
|
Histiocytosis, Sinus | 1 | 2013 | 47 | 0.120 |
Why?
|
Poland | 2 | 2014 | 184 | 0.120 |
Why?
|
Testicular Diseases | 1 | 2013 | 71 | 0.120 |
Why?
|
Gene Rearrangement | 3 | 2019 | 1179 | 0.110 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 143 | 0.110 |
Why?
|
Intestinal Neoplasms | 2 | 2006 | 319 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2005 | 2542 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2017 | 1581 | 0.110 |
Why?
|
Survival Rate | 9 | 2020 | 12773 | 0.110 |
Why?
|
Cesarean Section | 1 | 2021 | 1363 | 0.110 |
Why?
|
Neoplasms | 1 | 2021 | 21596 | 0.110 |
Why?
|
Rupture, Spontaneous | 2 | 2010 | 354 | 0.110 |
Why?
|
Peru | 1 | 2015 | 881 | 0.110 |
Why?
|
Sarcoma | 2 | 2022 | 1895 | 0.100 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2011 | 42 | 0.100 |
Why?
|
Intestinal Polyposis | 1 | 2011 | 44 | 0.100 |
Why?
|
Pancreas | 1 | 2018 | 1684 | 0.100 |
Why?
|
Myometrium | 2 | 2021 | 181 | 0.100 |
Why?
|
Pregnancy Trimester, Third | 1 | 2014 | 571 | 0.100 |
Why?
|
Denmark | 1 | 2013 | 736 | 0.100 |
Why?
|
Lymph Node Excision | 2 | 2015 | 1248 | 0.100 |
Why?
|
Rhabdoid Tumor | 2 | 2020 | 212 | 0.100 |
Why?
|
Anniversaries and Special Events | 1 | 2011 | 89 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2018 | 1101 | 0.100 |
Why?
|
Massachusetts | 2 | 2014 | 8662 | 0.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2011 | 140 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2002 | 3278 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2022 | 77098 | 0.090 |
Why?
|
Mucous Membrane | 2 | 2004 | 670 | 0.090 |
Why?
|
Immunoenzyme Techniques | 5 | 2011 | 1799 | 0.090 |
Why?
|
Ulcer | 1 | 2011 | 209 | 0.090 |
Why?
|
Acid Phosphatase | 2 | 2007 | 141 | 0.090 |
Why?
|
Pseudolymphoma | 1 | 2010 | 30 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1769 | 0.090 |
Why?
|
Orchitis | 1 | 2009 | 35 | 0.090 |
Why?
|
Cytoplasm | 2 | 2007 | 1539 | 0.090 |
Why?
|
Activin Receptors, Type II | 1 | 2010 | 127 | 0.090 |
Why?
|
Anti-Mullerian Hormone | 1 | 2012 | 399 | 0.090 |
Why?
|
Nuclear Proteins | 3 | 2020 | 5851 | 0.090 |
Why?
|
Lung Neoplasms | 3 | 2014 | 13019 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2004 | 5163 | 0.090 |
Why?
|
Telepathology | 1 | 2009 | 76 | 0.090 |
Why?
|
Cadherins | 2 | 2012 | 906 | 0.090 |
Why?
|
Carcinosarcoma | 2 | 2011 | 108 | 0.080 |
Why?
|
Kidney | 1 | 2004 | 7167 | 0.080 |
Why?
|
Vulvar Neoplasms | 1 | 2011 | 272 | 0.080 |
Why?
|
Microscopy, Electron | 2 | 2010 | 2645 | 0.080 |
Why?
|
Mediastinal Neoplasms | 1 | 2012 | 421 | 0.080 |
Why?
|
Wilms Tumor | 1 | 2011 | 368 | 0.080 |
Why?
|
Uterine Diseases | 1 | 2010 | 135 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1899 | 0.080 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2008 | 49 | 0.080 |
Why?
|
Diverticulum | 1 | 2009 | 136 | 0.080 |
Why?
|
Infant, Newborn | 2 | 2021 | 25575 | 0.080 |
Why?
|
Sweden | 2 | 2017 | 1343 | 0.080 |
Why?
|
Urogenital Neoplasms | 1 | 2010 | 135 | 0.080 |
Why?
|
History, 18th Century | 1 | 2009 | 214 | 0.080 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2008 | 61 | 0.080 |
Why?
|
Immunotherapy | 1 | 2004 | 4414 | 0.080 |
Why?
|
Tongue Neoplasms | 1 | 2010 | 179 | 0.080 |
Why?
|
Neoplasm Proteins | 4 | 2006 | 3691 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2007 | 473 | 0.080 |
Why?
|
Vacuoles | 1 | 2008 | 230 | 0.080 |
Why?
|
Uterus | 2 | 2023 | 710 | 0.080 |
Why?
|
Survival Analysis | 3 | 2014 | 10248 | 0.080 |
Why?
|
Urethral Neoplasms | 2 | 2004 | 40 | 0.070 |
Why?
|
Follow-Up Studies | 8 | 2022 | 39004 | 0.070 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2007 | 31 | 0.070 |
Why?
|
History, 16th Century | 1 | 2007 | 72 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2010 | 659 | 0.070 |
Why?
|
Remote Consultation | 1 | 2009 | 238 | 0.070 |
Why?
|
Mechanoreceptors | 1 | 2008 | 186 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3471 | 0.070 |
Why?
|
Gestational Age | 1 | 2015 | 3490 | 0.070 |
Why?
|
Gynecomastia | 1 | 2007 | 88 | 0.070 |
Why?
|
Cell Differentiation | 4 | 2016 | 11470 | 0.070 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2007 | 295 | 0.070 |
Why?
|
Antigens, Neoplasm | 2 | 2006 | 1983 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4211 | 0.070 |
Why?
|
Obesity | 1 | 2008 | 12705 | 0.070 |
Why?
|
Gene Fusion | 2 | 2020 | 371 | 0.070 |
Why?
|
Cystadenoma, Papillary | 1 | 2005 | 7 | 0.070 |
Why?
|
Mixed Tumor, Mesodermal | 1 | 2005 | 1 | 0.070 |
Why?
|
Cell Division | 2 | 2004 | 4564 | 0.070 |
Why?
|
Pelvis | 1 | 2010 | 730 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 5 | 2010 | 20086 | 0.070 |
Why?
|
Doxorubicin | 1 | 2012 | 2215 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2005 | 6754 | 0.060 |
Why?
|
Carcinoma, Large Cell | 1 | 2005 | 113 | 0.060 |
Why?
|
Flank Pain | 1 | 2004 | 43 | 0.060 |
Why?
|
Phyllodes Tumor | 1 | 2004 | 53 | 0.060 |
Why?
|
Leiomyomatosis | 1 | 2004 | 70 | 0.060 |
Why?
|
Fallopian Tubes | 1 | 2005 | 182 | 0.060 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 76 | 0.060 |
Why?
|
Fibrosarcoma | 1 | 2006 | 348 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2005 | 524 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 713 | 0.060 |
Why?
|
Maryland | 1 | 2004 | 276 | 0.060 |
Why?
|
Europe | 2 | 2015 | 3339 | 0.060 |
Why?
|
Meigs Syndrome | 1 | 2003 | 6 | 0.060 |
Why?
|
Uterine Cervicitis | 1 | 2003 | 30 | 0.060 |
Why?
|
Muscle, Smooth | 2 | 2006 | 933 | 0.060 |
Why?
|
Postmenopause | 1 | 2013 | 2461 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1376 | 0.060 |
Why?
|
Cystoscopy | 1 | 2004 | 134 | 0.060 |
Why?
|
Intermediate Filament Proteins | 1 | 2004 | 269 | 0.060 |
Why?
|
Erectile Dysfunction | 1 | 2007 | 459 | 0.060 |
Why?
|
Mycobacterium bovis | 1 | 2004 | 150 | 0.060 |
Why?
|
Virus Diseases | 1 | 2009 | 710 | 0.060 |
Why?
|
Age of Onset | 1 | 2010 | 3266 | 0.060 |
Why?
|
Penis | 1 | 2004 | 216 | 0.060 |
Why?
|
Torsion Abnormality | 1 | 2003 | 93 | 0.060 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2003 | 428 | 0.060 |
Why?
|
Circumcision, Male | 1 | 2004 | 150 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20774 | 0.050 |
Why?
|
Ureteral Obstruction | 1 | 2004 | 293 | 0.050 |
Why?
|
Mucin-1 | 2 | 2004 | 543 | 0.050 |
Why?
|
Nephrectomy | 2 | 2007 | 1049 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2005 | 317 | 0.050 |
Why?
|
Thrombomodulin | 1 | 2003 | 102 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2556 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 194 | 0.050 |
Why?
|
Pregnancy, Ectopic | 1 | 2003 | 141 | 0.050 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2004 | 252 | 0.050 |
Why?
|
Recurrence | 2 | 2004 | 8333 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2186 | 0.050 |
Why?
|
Ureter | 1 | 2004 | 374 | 0.050 |
Why?
|
Eosinophils | 1 | 2007 | 953 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3461 | 0.050 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2010 | 987 | 0.050 |
Why?
|
Human papillomavirus 18 | 1 | 2022 | 128 | 0.050 |
Why?
|
Serous Membrane | 1 | 2021 | 28 | 0.050 |
Why?
|
Urethra | 1 | 2004 | 408 | 0.050 |
Why?
|
Cisplatin | 2 | 2007 | 1637 | 0.050 |
Why?
|
Genes, p53 | 1 | 2024 | 755 | 0.050 |
Why?
|
Curettage | 1 | 2021 | 73 | 0.050 |
Why?
|
Mullerian Ducts | 1 | 2002 | 198 | 0.050 |
Why?
|
Urothelium | 1 | 2003 | 277 | 0.050 |
Why?
|
Histone Deacetylases | 1 | 2006 | 729 | 0.050 |
Why?
|
Urologic Surgical Procedures | 1 | 2004 | 301 | 0.050 |
Why?
|
Trisomy | 1 | 2002 | 266 | 0.050 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 548 | 0.050 |
Why?
|
Societies, Medical | 1 | 2013 | 3740 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8829 | 0.050 |
Why?
|
Lymphoma | 1 | 2010 | 1873 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2004 | 780 | 0.050 |
Why?
|
Human papillomavirus 16 | 1 | 2022 | 262 | 0.050 |
Why?
|
Oncogene Fusion | 1 | 2020 | 99 | 0.050 |
Why?
|
Vomiting | 1 | 2003 | 632 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2004 | 2027 | 0.050 |
Why?
|
Ossification, Heterotopic | 1 | 2002 | 239 | 0.040 |
Why?
|
Epithelium | 1 | 2004 | 1680 | 0.040 |
Why?
|
Apoptosis | 1 | 2015 | 9715 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2007 | 1413 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1363 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2004 | 545 | 0.040 |
Why?
|
X Chromosome | 1 | 2002 | 815 | 0.040 |
Why?
|
Canada | 1 | 2004 | 2061 | 0.040 |
Why?
|
Radiation Oncology | 1 | 2005 | 554 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 40450 | 0.040 |
Why?
|
Cystectomy | 1 | 2004 | 682 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2004 | 1599 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2002 | 668 | 0.040 |
Why?
|
Synaptophysin | 2 | 2007 | 141 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2002 | 1099 | 0.040 |
Why?
|
Genes, APC | 1 | 2018 | 159 | 0.040 |
Why?
|
Phenotype | 3 | 2019 | 16331 | 0.040 |
Why?
|
Spinal Neoplasms | 1 | 2004 | 759 | 0.040 |
Why?
|
Abdomen | 1 | 2003 | 1107 | 0.040 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 1786 | 0.040 |
Why?
|
Hepatocytes | 1 | 2004 | 1209 | 0.040 |
Why?
|
Chromogranins | 2 | 2007 | 163 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2012 | 13655 | 0.040 |
Why?
|
Antigens, CD | 2 | 2004 | 4024 | 0.040 |
Why?
|
General Surgery | 1 | 2008 | 1633 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2022 | 1118 | 0.030 |
Why?
|
Microdissection | 1 | 2015 | 152 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2417 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3507 | 0.030 |
Why?
|
Ultrasonography | 2 | 2007 | 5978 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2015 | 166 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1251 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 314 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2924 | 0.030 |
Why?
|
Mosaicism | 1 | 2017 | 440 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4839 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2010 | 3497 | 0.030 |
Why?
|
Stents | 1 | 2004 | 3276 | 0.030 |
Why?
|
Expert Testimony | 1 | 2015 | 356 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3769 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2004 | 2211 | 0.020 |
Why?
|
World Health Organization | 1 | 2016 | 1317 | 0.020 |
Why?
|
G1 Phase | 1 | 2012 | 415 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2011 | 587 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 692 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4933 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12344 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 553 | 0.020 |
Why?
|
Prevalence | 1 | 2006 | 15194 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2593 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 382 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
China | 1 | 2014 | 2246 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2004 | 4249 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5692 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17400 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2906 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2253 | 0.020 |
Why?
|
Clone Cells | 1 | 2010 | 1692 | 0.020 |
Why?
|
Risk Factors | 2 | 2011 | 72145 | 0.020 |
Why?
|
History, 17th Century | 1 | 2006 | 111 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 2935 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1950 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1758 | 0.020 |
Why?
|
Point Mutation | 1 | 2011 | 1624 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7716 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1866 | 0.020 |
Why?
|
von Hippel-Lindau Disease | 1 | 2005 | 152 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 20928 | 0.010 |
Why?
|
Epididymis | 1 | 2005 | 227 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1596 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6171 | 0.010 |
Why?
|
Age Factors | 2 | 2011 | 18355 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8077 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8436 | 0.010 |
Why?
|
Family | 1 | 2011 | 3144 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23320 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4801 | 0.010 |
Why?
|
Animals | 2 | 2012 | 168561 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2007 | 2906 | 0.010 |
Why?
|
Apyrase | 1 | 2002 | 364 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9735 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10372 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9679 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7790 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14720 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2002 | 774 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13256 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2002 | 836 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1081 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13403 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2002 | 1152 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 35342 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2007 | 3465 | 0.010 |
Why?
|
MicroRNAs | 1 | 2011 | 3731 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9410 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7276 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23387 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19862 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2004 | 7873 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81045 | 0.000 |
Why?
|